Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats

Neuroscience Bulletin

Volumn 30, Issue 6, 2014, Pages 923-935

  Chai, Gao Shang ^a,b   Duan, Dong Xiao ^a,c   Ma, Rong Hong ^d   Shen, Jian Ying ^a   Li, Hong Lian ^a   Ma, Zhi Wei ^a   Luo, Yu ^a   Wang, Lu ^a   Qi, Xin Hua ^e   Wang, Qun ^a   Wang, Jian Zhi ^a   Wei, Zelan ^f   Mousseau, Darrell D ^f   Wang, Li ^g   Liu, Gongping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JIANGNAN UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e HEBEI UNIVERSITY OF ENGINEERING   (China)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

^g Henan Engineering College   (China)

Author keywords

Alzheimer s disease; amyloid beta; apoptosis; Humanin; tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; HUMANIN; PHOSPHOPROTEIN PHOSPHATASE 2A; SIGNAL PEPTIDE;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITIC SPINE; LONG TERM POTENTIATION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN PHOSPHORYLATION; ANIMAL; BRAIN; CHEMICALLY INDUCED; COGNITION; COGNITION DISORDERS; DENDRITE; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; MAZE TEST; NERVE CELL; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; PSYCHOLOGY; RAT; WISTAR RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; COGNITION; COGNITION DISORDERS; DENDRITES; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAZE LEARNING; NEURONS; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; RATS, WISTAR;

EID: 84914697213     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-014-1479-3     Document Type: Article

References (59)

1. Alonso AD, Grundke-Iqbal I, Barra HS Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A 1997, 94: 298–303.
2. Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 2005, 25, 10637–10647.
3. Terry RD. Cell death or synaptic loss in Alzheimer disease. J Neuropathol Exp Neurol 2000, 59: 1118–1119.
4. Paulson JB, Ramsden M, Forster C, Sherman MA, McGowan E, Ashe KH. Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer’s disease. Am J Pathol 2008, 173: 762–772.
5. Mount C, Downton C. Alzheimer disease: progress or profit? Nat Med 2006, 12: 780–784.
6. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002, 297: 353–356.
7. Sisodia SS, St GP. gamma-Secretase, Notch, Abeta and Alzheimer’s disease: where do the presenilins fit in? Nat Rev Neurosci 2002, 3: 281–290.
8. Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001, 293: 1491–1495.
9. Lippa CF, Nee LE, Mori H, St GP. Abeta-42 deposition precedes other changes in PS-1 Alzheimer’s disease. Lancet 1998, 352: 1117–1118.
10. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, et al. beta-Amyloid-(1–42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci U S A 1993, 90: 10836–10840.
11. Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer’s disease. Am J Pathol 2004, 165: 523–531.
12. McPhie DL, Coopersmith R, Hines-Peralta A, Chen Y, Ivins KJ, Manly S, et al. DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3. J Neurosci 2003, 23: 6914–6927.
13. Yu W, Mechawar N, Krantic S, Quirion R. Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease. Am J Pathol 2010, 176: 2209–2218.
14. Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, et al. Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med 2005, 11: 545–550.
15. Moonis M, Swearer JM, Dayaw MP, St GP, Rogaeva E, Kawarai T, et al. Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline. Neurology 2005, 65: 323–325.
16. Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, et al. ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 2012, 335: 1503–1506
17. Hashimoto Y, Ito Y, Niikura T, Shao Z, Hata M, Oyama F, et al. Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein. Biochem Biophys Res Commun (2001a), 283: 460–468.
18. Nishimoto I, Matsuoka M, Niikura T. Unravelling the role of Humanin. Trends Mol Med 2004, 10: 102–105.
19. Chiba T, Yamada M, Hashimoto Y, Sasabe J, Kita Y, Terashita K, et al. Development of a femtomolar-acting humanin derivative named colivelin by attaching activity-dependent neurotrophic factor to its N terminus: characterization of colivelin-mediated neuroprotection against Alzheimer’s disease-relevant insults in vitro and in vivo. J Neurosci 2005, 25: 10252–10261.
20. Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer’s disease genes and Abeta. Proc Natl Acad Sci U S A 2001b, 98: 6336–6341.
21. Hashimoto Y, Niikura T, Ito Y, Sudo H, Hata M, Arakawa E, et al. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer’s disease-relevant insults. J Neurosci 2001c, 21: 9235–9245.
22. Ikonen M, Liu B, Hashimoto Y, Ma L, Lee KW, Niikura T, et al. Interaction between the Alzheimer’s survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci U S A 2003, 100: 13042–13047.
23. Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S. Humanin inhibits cell death of serum-deprived PC12h cells. Neuroreport 2002, 13: 903–907.
24. Wang D, Li H, Yuan H, Zheng M, Bai C, Chen L, et al. Humanin delays apoptosis in K562 cells by downregulation of P38 MAP kinase. Apoptosis 2005, 10: 963–971.
25. Pike CJ, Nguyen TV, Ramsden M, Yao M, Murphy MP, Rosario ER. Androgen cell signaling pathways involved in neuroprotective actions. Horm Behav 2008, 53: 693–705.
26. Frautschy SA, Baird A, Cole GM. Effects of injected Alzheimer beta-amyloid cores in rat brain. Proc Natl Acad Sci U S A 1991, 88: 8362–8366.
27. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11: 47–60.
28. Tu W, Xu X, Peng L, Zhong X, Zhang W, Soundarapandian MM, et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 2010, 140: 222–234.
29. Chai GS, Jiang X, Ni ZF, Ma ZW, Xie AJ, Cheng XS, et al. Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine. J Neurochem 2013, 124: 388–396.
30. Zhu LQ, Liu D, Hu J, Cheng J, Wang SH, Wang Q, et al. GSK-3 beta inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type calcium channel and interrupting SNARE complex formation. J Neurosci 2010, 30: 3624–3633.
31. Liu SJ, Zhang JY, Li HL, Fang ZY, Wang Q, Deng HM, et al. Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain. J Biol Chem 2004, 279, 50078–50088.
32. Yang Y, Shu X, Liu D, Shang Y, Wu Y, Pei L, et al. EPAC Null Mutation Impairs Learning and Social Interactions via Aberrant Regulation of miR-124 and Zif268 Translation. Neuron 2012, 73: 774–788.
33. Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung YC, Zaidi, T. Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci U S A 1989, 86: 5646–5650.
34. Liu F, Liang Z, Gong CX. Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease. Panminerva Med 2006, 48: 97–108.
35. Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer’s disease brain: central role for amyloid beta-peptide. Trends Mol Med 2001, 7: 548–554.
36. Reddy PH. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer’s disease. J Neurochem 2006, 96: 1–13.
37. We Z, Song MS, MacTavish D, Jhamandas JH, Kar S. Role of calpain and caspase in beta-amyloid-induced cell death in rat primary septal cultured neurons. Neuropharmacology 2008, 54: 721–733
38. Wilkinson BL, Cramer PE, Varvel NH, Reed-Geaghan E, Jiang Q, Szabo A, et al. Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer’s disease. Neurobiol Aging 2012, 33: 121–197.
39. Murray IV, Sindoni ME, Axelsen PH. Promotion of oxidative lipid membrane damage by amyloid beta proteins. Biochemistry-Us 2005, 44: 12606–12613.
40. Bachar AR, Scheffer L, Schroeder AS, Nakamura HK, Cobb LJ, Oh YK, et al. Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress. Cardiovasc Res 2010, 88: 360–366.
41. Mamiya T, Ukai M. [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br J Pharmacol 2001, 134: 1597–1599.
42. Niikura T, Sidahmed E, Hirata-Fukae C, Aisen PS, Matsuoka Y. A humanin derivative reduces amyloid beta accumulation and ameliorates memory deficit in triple transgenic mice. PLoS One 2011, 6: e16259.
43. Richter-Levin G, Segal M. The effects of serotonin depletion and raphe grafts on hippocampal electrophysiology and behavior. J Neurosci 1991, 11: 1585–1596.
44. Greengard P, Valtorta F, Czernik AJ, Benfenati F. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 1993, 259: 780–785.
45. Pieribone VA, Shupliakov O, Brodin L, Hilfiker-Rothenfluh S, Czernik AJ, Greengard P. Distinct pools of synaptic vesicles in neurotransmitter release. Nature 1995, 375: 493–497.
46. Slutsky I, Abumaria N, Wu LJ, Huang C, Zhang L, Li B, et al. Enhancement of learning and memory by elevating brain magnesium. Neuron 2010, 65: 165–177.
47. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 1986, 83: 4913–4917.
48. Wang JZ, Gong CX, Zaidi T, Grundke-Iqbal I, Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem 1995, 270: 4854–4860.
49. Tian Q, Wang J. Role of serine/threonine protein phosphatase in Alzheimer’s disease. Neurosignals 2002, 11: 262–269.
50. Jung SS, Van Nostrand WE. Humanin rescues human cerebrovascular smooth muscle cells from Abeta-induced toxicity. J Neurochem 2003, 84: 266–272.
51. Hashimoto Y, Suzuki H, Aiso S, Niikura T, Nishimoto I, Matsuoka M. Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection. Life Sci 2005, 77: 3092–3104.
52. Caricasole A, Bruno V, Cappuccio I, Melchiorri D, Copani A, Nicoletti F. A novel rat gene encoding a Humanin-like peptide endowed with broad neuroprotective activity. FASEB J 2002, 16: 1331–1333.
53. Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, Satterthwait AC, et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 2003, 423: 456–461.
54. Butterfield DA, Bush AI. Alzheimer’s amyloid beta-peptide (1–42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Neurobiol Aging 2004, 25: 563–568.
55. Mattson MP. Pathways towards and away from Alzheimer’s disease. Nature 2004, 430: 631–639.
56. Hashimoto Y, Niilura T, Jajima H, Yasukawa T, Sudo H, Ito Y, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer’s disease genes and Abeta. Proc Natl Acad Sci U S A 2001, 98: 6336–6341.
57. Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, Satterthwait AC, et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 2003, 423: 456–461.
58. Hashimoto Y, Niilura T, Chiba T, Tsukamoto E, Kadowaki H, Nishitoh H, et al. The cytoplasmic domain of Alzheimer’s amyloid-b protein precursor causes sustained ASK1/JNK mediated neurotoxic signal via dimerization. J Pharmacol Exp Ther 2003, 306: 889–902.
59. Hashimoto Y, Kurita M, Aiso S, Nishimoto I, Matsuoka M. Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130. Mol Biol Cell 2009, 20: 2864–2873.